MTOR and tuberous sclerosis: Recently, the retrospective analysis of TSC patients treated with everolimus or sirolimus under the age of 2 years has reported promising benefits on epilepsy.191 This study for the basis for the testing of mTOR inhibition in a large cohort of patients with TSC.